Introduction
potential to serve as a renewable source of cells for regenerative therapies as required by that then identifying and destroying any residual pluripotent cells from the graft. Although several methods have been developed, the efficacy of these to prevent the formation of teratomas in 183 vivo remains unproven (Wu and Hochedlinger, 2011 (Pittenger et al., 1999) . Recent studies have demonstrated that they are also able to 188 form pancreatic islet cells (Santos et al., 2010) , hepatocytes (Lee et al., 2004; Ong et al., 189 2006) and neurons (Woodbury et al., 2000) in vitro. In humans, MSCs are typically isolated Many studies have described the isolation of MSCs from a range of canine tissues, 198 including adipose tissue (Neupane et al., 2008; Vieira et al., 2010; Kisiel et al., 2012; Reich et 199 al., 2012; Takemitsu et al., 2012) , bone marrow (Kisiel et al., 2012; Reich et al., 2012; 200 Takemitsu et al., 2012), muscle (Kisiel et al., 2012) , periosteum (Kisiel et al., 2012) and 201 synovium (Zhang et al., 2013) . Similarly diverse sources have been identified for equine
202
MSCs (Hegewald et al., 2004; Koch et al., 2007; Crovace et al., 2010; Raabe et al., 2011; 203 Ranera et al., 2012; Burk et al., 2013; Barberini et al., 2014; De Schauwer et al., 2014) , as 204 well as caprine (Murphy et al., 2003) , ovine (Jager et al., 2006; Mrozik et al., 2010) and 205 porcine (Wang et al., 2008; Cao et al., 2011; Miernik and Karasinski, 2012 However, a common feature of MSCs, irrespective of species-of-origin, is that they 229 represent a very small fraction of the cells isolated from both bone marrow and adipose tissue 230 (0.001-0.01% and 0.05%, respectively) for human tissues (Kern et al., 2006; Bieback et al., 2008) . Also, in both humans and dogs, the quality and quantity of MSCs that can be collected 232 decline with increasing age of the donor (Stolzing et al., 2008; Zhou et al., 2008; Kisiel et al., 233 2012; Guercio et al., 2013; Zhang et al., 2013) In an attempt to circumvent the decreased capacity for proliferation and differentiation 241 of adult MSCs, we and others (Lian et al., 2010; Chen et al., 2012; Whitworth et al., 2014b) 242 have produced MSCs from iPSCs. In humans, these iPSC-derived MSCs resemble primary, 
Can mesenchymal stem cells effect cartilage repair in animals with osteoarthritis?

258
Many studies have been performed on a variety of animal species testing the efficacy of
259
MSCs at repairing damaged cartilage in both naturally occurring and induced models of 260 osteoarthritis. While space limitations prevent us from being able to discuss each published 261 study, the salient points from each are summarised in Tables 1 and 2 . However, it is 262 important to consider key observations that can be extracted from the literature. The timing of MSC treatment with respect to the onset of osteoarthritis also seems to be 315 a key factor in the degree to which MSCs modulate the progression of cartilage destruction. Bao, L., He, L., Chen, J., Wu, Z., Liao, J., Rao, L., Ren, J., Li, H., Zhu, H., Qian, L., et al., Black, L.L., Gaynor, J., Adams, C., Dhupa, S., Sams, A.E., Taylor, R., Harman, S., Zhou, S., Greenberger, J.S., Epperly, M.W., Goff, J.P., Adler, C., Leboff, M.S., Glowacki, J., 
